Stock Comparison
ABBV vs MRK
AbbVie Inc and Merck & Company Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$317.77B
P/E (TTM)
123.6
36.2
Forward P/E
17.8
25.5
Price/Sales
7.1
4.8
Price/Book
50.5
6.9
EV/EBITDA
30.2
18.6
Dividend Yield
2.77%
2.61%
Profitability
Net Margin
5.79%
13.60%
Operating Margin
32.20%
38.60%
Return on Equity
62.30%
18.90%
Return on Assets
10.00%
12.60%
Growth (YoY)
Revenue Growth
12.40%
4.90%
Earnings Growth
-46.20%
-19.30%
Price & Risk
Beta
0.3
0.2
52-Week High
$253.35
$128.78
52-Week Low
$176.02
$74.18
Analyst Target
$254.38
$130.39
Compare ABBV and MRK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.